About: Denis Angoulvant

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Denis Angoulvant Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) araştırmacı (tr) дослідник (uk) эрдэмтэн (mn) वैज्ञानिक (hi) հետազոտող (hy) onderzoeker (nl)
rdfs:label	Denis Angoulvant (en) Denis Angoulvant (es) Denis Angoulvant (nl) Denis Angoulvant (ast)
skos:prefLabel	Denis Angoulvant (en) Denis Angoulvant (es) Denis Angoulvant (nl) Denis Angoulvant (ast)
name	Denis Angoulvant (en) Denis Angoulvant (es) Denis Angoulvant (nl) Denis Angoulvant (ast)
Scopus author ID	wds:Q57243849-80F58C17-8B33-433C-8A1D-D3867A5E5FA6
Scopus author ID	8871599800
given name	wds:Q57243849-50DDB19D-C6E0-4857-81BF-D95D8A00875D
given name	Denis
instance of	wds:Q57243849-C4CFA10B-B45E-4F40-803D-1DBE9A0514BC
instance of	Homo sapiens
occupation	wds:Q57243849-E8B7D809-5E00-4A3A-A4AE-71F076EBA625
employer	wds:Q57243849-5BA2C7D7-0B2B-4EEF-B444-ED5696459C04
sex or gender	wds:Q57243849-E4573FE3-B6DA-4D1D-B51D-135601661F3F
ISNI	wds:Q57243849-FE74F8EE-0233-4461-84E6-DE05E165F133
VIAF ID	wds:Q57243849-1DB29D6C-45D3-4096-B5BA-425482A173D9
IdRef ID	wds:Q57243849-CC1C6CDC-6FED-47BF-964B-4D67178EEAB6
date of birth	wds:Q57243849-4D504724-9CD3-4A9D-92D3-A58E0C2A39DA
educated at	wds:Q57243849-15D2DA4A-2D0C-4AFB-9237-BF7980F7337D wds:Q57243849-CD6330BA-BE28-400D-AA1A-5B432841DA3C wds:Q57243849-DBF06AFA-63D9-4E75-BF7A-895FC2370E78 wds:Q57243849-F37245AD-32DF-46AD-BFBB-253AB19E594F
VIAF ID	http://viaf.org/viaf/203081850
IdRef ID	http://www.idref.fr/061089141/id
occupation	researcher
employer	Tours University
sex or gender	male
ISNI	0000000358007558
VIAF ID	203081850
IdRef ID	061089141
date of birth	1970-01-01 00:00:00Z (xsd:dateTime)
educated at	University of Toronto Claude Bernard University Lyon 1
ORCID iD	wds:Q57243849-0EAC7772-4CE3-4E92-8E75-0C5991155171
ORCID iD	https://orcid.org/0000-0003-0788-8092
ORCID iD	0000-0003-0788-8092
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57243849
is author of	Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction Long-term benefit of postconditioning Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines Effect of cyclosporine on reperfusion injury in acute myocardial infarction Cyclosporine protects the heart during aortic valve surgery. The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction. Cyclosporine before PCI in Patients with Acute Myocardial Infarction Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. Neovascularization derived from cell transplantation in ischemic myocardium. Hypoxia/Reoxygenation Inhibits P2Y11 Receptor Expression and Its Immunosuppressive Activity in Human Dendritic Cells. Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. Post-conditioning protects from cardioplegia and cold ischemia via inhibition of mitochondrial permeability transition pore Volatile anaesthetics and cardioprotection: lessons from animal studies. Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential. Ischaemic postconditioning reduces infarct size: systematic review and meta-analysis of randomized controlled trials. Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modelling Postconditioning attenuates no-reflow in STEMI patients Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty How to define valvular atrial fibrillation? Remote ischemic preconditioning in aortic valve surgery: Results of a randomized controlled study. Cardiac fibroblasts protect cardiomyocytes against lethal ischemia-reperfusion injury. Immature human dendritic cells enhance their migration through KCa3.1 channel activation. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project. In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study. Lack of microsomal prostaglandin E(2) synthase-1 in bone marrow-derived myeloid cells impairs left ventricular function and increases mortality after acute myocardial infarction. False positive results in preclinical research. Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation [Monoclonal antibodies in cardiovascular diseases and metabolic disorders today] Efficacy of new oral anticoagulants in patients with atrial fibrillation previously treated with warfarin: a meta-analysis of randomized controlled trials Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated? Causes of Death and Influencing Factors in Patients with Atrial Fibrillation. The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway. Stimulation of P2Y11 receptor protects human cardiomyocytes against Hypoxia/Reoxygenation injury and involves PKCε signaling pathway The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytes Lack of group X secreted phospholipase A₂ increases survival following pandemic H1N1 influenza infection. Regionalization of services improves access to emergency vascular surgical care Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients. Septic shock caused by Mycobacterium tuberculosis in a non-HIV patient Cell transplantation for heart disease: the clinical perspective Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software